Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2023-02-03 10:44 am Unchanged | 13G | Gene Biotherapeutics Inc. CRXM | Jemapete Christopher J | 4,000,000 6.200% | 0 (Unchanged) | View |
| 2023-02-03 10:33 am Sale | 13G | BLUE BIOFUELS INC BIOF | Jemapete Christopher J | 2,600,000 0.900% | -9,075,000 (-77.73%) | View |
| 2022-01-24 5:23 pm Purchase | 13G | BLUE BIOFUELS INC BIOF | Jemapete Christopher J | 11,675,000 4.300% | 11,675,000 (New Position) | View |
| 2021-04-28 4:20 pm Unchanged | 13G | Gene Biotherapeutics Inc. CRXM | Jemapete Christopher J | 4,000,000 8.100% | 0 (Unchanged) | View |
| 2021-03-18 2:05 pm Purchase | 13D | Gene Biotherapeutics Inc. CRXM | Jemapete Christopher J | 4,000,000 27.600% | 500,000 (+14.29%) | View |
| 2021-03-05 08:00 am Sale | 13G | BLUE BIOFUELS INC BIOF | Jemapete Christopher J | 12,275,000 5.100% | -2,225,000 (-15.34%) | View |
| 2021-03-01 4:48 pm Purchase | 13D | Gene Biotherapeutics Inc. CRXM | Jemapete Christopher J | 3,500,000 24.200% | 3,500,000 (New Position) | View |